Retinopathy in a Chinese population with type 2 diabetes: factors affecting the presence of this complication at diagnosis of diabetes

References 

1. Sorsby A. The incidence and causes of blindness in England and Wales 1963–1968. Reports on Public Health and Medical Subjects. 1963;128(1972):1–72
2. See JL, Wong TY, Yeo KT. Trends in the pattern of blindness and major ocular diseases in Singapore and Asia. Annals of the Academy of Medicine Singapore. 1998;27:540–546
3. Brooks B, Chong R, Ho I, et al.  Diabetic retinopathy and nephropathy in Fiji: comparison with data from an Australian diabetes centre. Australian & New Zealand Journal of Ophthalmology. 1999;27:9–13
4. Pan XR, Yang WY, Li GW, Liu J. Prevalence of diabetes and its risk factors in China, National Diabetes Prevention and Control Cooperative Group, 1994. Diabetes Care. 1997;20:1664–1669
   • MEDLINE
5. Pan CY, Lu JM, Tian H, et al.  Study of the prevalence of diabetes mellitus in adults in the Shougang Corporation in Beijing. Diabetic Medicine. 1996;13:663–668
6. Hu YH, Pan XR, Liu PA, Li GW, Howard BV, Bennett PH. Coronary heart disease and diabetic retinopathy in newly diagnosed diabetes in Da Qing, China: the Da Qing IGT and Diabetes study. Acta Diabetologica. 1991;28:169–173
   • MEDLINE
   • CrossRef
7. He S, Guo Y, Li Z. Epidemiologic study of diabetic retinopathy in Capital Steel Company. Chung-Hua Yen Ko Tsa Chih. 1997;33:381–383
8. K.G.M.M. Alberti, P.Z. Zimmet for the WHO Consultation, Definition, diagnosis and classification of diabetes mellitus and its complications Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation, Diabetic Medicine, 15 (1998) 539–553.
9. Consensus Statement of the American Diabetes Association. Treatment of hypertension in diabetes, Diabetes Care 16 (1993) 1394–1401.
10. National Health and Medical Research Council of Australia. Management of diabetic retinopathy; Clinical Practice Guidelines (1997) 1–94.
11. Harris MI, Klein R, Welborn TA, Knuimanl MW. Onset of NIDDM occurs at least 4–7 years before clinical diagnosis. Diabetes Care. 1992;15:815–819
    • MEDLINE
12. Wang WQ, Ip TP, Lam KS. Changing prevalence of retinopathy in newly diagnosed non-insulin dependent diabetes mellitus patients in Hong Kong. Diabetes Research and Clinical Practice. 1998;39:185–191
    • Abstract
    • Full Text
    • Full-Text PDF (95 KB)
    • CrossRef
13. Dowse GK, Humphrey AR, Collins VR, et al.  Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius. American Journal of Epidemiology. 1998;147:448–457
    • MEDLINE
    • CrossRef
14. Xu Z, Wang Y, Wang X. Chronic diabetic complications and treatments in Chinese diabetic patients. Chung-Hua i Hsueh Tsa Chih. 1997;77:119–122
15. Yu PL, Yao Y, Yang Z. Multifactor analysis on proliferative retinopathy in elderly patients with type II diabetes. Chung-Hua Liu Hsing Ping Hsueh Tsa Chih. 1997;18:286–288
16. Sobngwi E, Mbanya JC, Moukouri EN, Ngu KB. Microalbuminuria and retinopathy in a diabetic population of Cameroon. Diabetes Research and Clinical Practice. 1999;44:191–196
    • Abstract
    • Full Text
    • Full-Text PDF (135 KB)
    • CrossRef
17. Yue DK, Molyneaux L, Ross GP, Constantino MI, Child AG, Turtle JR. Why does ethnicity affect prevalence of gestational diabetes? The underwater volcano theory. Diabetic Medicine. 1996;13:748–752